Share capital increase from exercise of warrants

As a consequence of the exercise of 170,001 warrants in Vaccibody AS, the share capital of Vaccibody AS has increased by NOK 1,700.01 from NOK 2,870,117.09 to NOK 2,871,817.10. The number of outstanding shares in the company has increased by 170,001 from 287,011,709 to 287,181,710 each with a par value of NOK 0.01. The warrants were exercised by an employee at a strike price of NOK 4.00 per share.